These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10655475)

  • 1. Rational discovery of novel nuclear hormone receptor antagonists.
    Schapira M; Raaka BM; Samuels HH; Abagyan R
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1008-13. PubMed ID: 10655475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear hormone receptor targeted virtual screening.
    Schapira M; Abagyan R; Totrov M
    J Med Chem; 2003 Jul; 46(14):3045-59. PubMed ID: 12825943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design.
    Ye Y; Liao Q; Wei J; Gao Q
    Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.
    Wurtz JM; Egner U; Heinrich N; Moras D; Mueller-Fahrnow A
    J Med Chem; 1998 May; 41(11):1803-14. PubMed ID: 9599231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Unexpected Mode Of Binding Defines BMS948 as A Full Retinoic Acid Receptor β (RARβ, NR1B2) Selective Agonist.
    Nadendla E; Teyssier C; Delfosse V; Vivat V; Krishnasamy G; Gronemeyer H; Bourguet W; Germain P
    PLoS One; 2015; 10(5):e0123195. PubMed ID: 25933005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.
    Park SJ; Kufareva I; Abagyan R
    J Comput Aided Mol Des; 2010 May; 24(5):459-71. PubMed ID: 20455005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
    Suetsugi M; Su L; Karlsberg K; Yuan YC; Chen S
    Mol Cancer Res; 2003 Nov; 1(13):981-91. PubMed ID: 14638870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
    Wang L; Zuercher WJ; Consler TG; Lambert MH; Miller AB; Orband-Miller LA; McKee DD; Willson TM; Nolte RT
    J Biol Chem; 2006 Dec; 281(49):37773-81. PubMed ID: 16990259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure.
    Jacobs MN; Dickins M; Lewis DF
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):117-32. PubMed ID: 12710995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.
    Pissios P; Tzameli I; Kushner P; Moore DD
    Mol Cell; 2000 Aug; 6(2):245-53. PubMed ID: 10983973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.
    Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G
    J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.
    Fan F; Hu R; Munzli A; Chen Y; Dunn RT; Weikl K; Strauch S; Schwandner R; Afshari CA; Hamadeh H; Nioi P
    Toxicol Sci; 2015 Jun; 145(2):283-95. PubMed ID: 25752796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
    Greschik H; Flaig R; Renaud JP; Moras D
    J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-protein interactions in nuclear receptors of hormones.
    Egea PF; Klaholz BP; Moras D
    FEBS Lett; 2000 Jun; 476(1-2):62-7. PubMed ID: 10878252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
    Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
    J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism.
    Kallen J; Lattmann R; Beerli R; Blechschmidt A; Blommers MJ; Geiser M; Ottl J; Schlaeppi JM; Strauss A; Fournier B
    J Biol Chem; 2007 Aug; 282(32):23231-9. PubMed ID: 17556356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors.
    Lakkaraju SK; Yu W; Raman EP; Hershfeld AV; Fang L; Deshpande DA; MacKerell AD
    J Chem Inf Model; 2015 Mar; 55(3):700-8. PubMed ID: 25692383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.
    Kojetin DJ; Burris TP
    Mol Pharmacol; 2013 Jan; 83(1):1-8. PubMed ID: 22869589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluation.
    Rey J; Hu H; Kyle F; Lai CF; Buluwela L; Coombes RC; Ortlund EA; Ali S; Snyder JP; Barrett AG
    ChemMedChem; 2012 Nov; 7(11):1909-14. PubMed ID: 22961990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.